TriStar2S LB 942 with HTRF-Technology

Product News   Apr 16, 2015

 
TriStar2S LB 942 with HTRF-Technology
 
 
FURTHER INFORMATION
 
 
 

Related Product News

New Insights into Hookipa’s TheraT® Replicating Viral Vector Platform Published in Immunity

Product News

TheraT®-induced CD8+ T cells are qualitatively differentiated from CD8+ T cells induced by other vector systems; they have a much higher capacity to kill target cells in tissues.

READ MORE

Zymeworks and Daiichi Sankyo Expand Immuno-Oncology Collaboration Focused on Bispecific Antibodies

Product News

Two additional licenses granted; upfront payment of US$18 million; total potential transaction value of up to US$484.7 million.

READ MORE

Bio-Rad Introduces Anti-Vedolizumab Antibodies

Product News

Antibodies Used to Support Research into the Treatment of Ulcerative Colitis and Crohn’s Disease.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE